Literature DB >> 27260336

Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis.

Giuseppe Derosa1,2,3, Pamela Maffioli4,5, Željko Reiner6, Luis E Simental-Mendía7, Amirhossein Sahebkar8.   

Abstract

PURPOSE: The aim of this study was to ascertain the effect size of statins in modulating plasma uric acid concentrations. DATA SOURCES: A search was undertaken of the MEDLINE, SCOPUS, Web of Science and Google Scholar electronic databases. STUDY SELECTION: Studies meeting the following criteria were included: (i) randomized controlled trials with either a parallel or crossover design; (ii) investigated the impact of statin therapy on plasma uric acid concentrations; and (iii) presentation of sufficient information on uric acid values at baseline and at the end of follow-up in each group, or presenting the net change. DATA SYNTHESIS: The present meta-analysis suggested a significant reduction in plasma uric acid levels following statin therapy; however, this does not seem to be a class effect as subgroup analysis revealed a significant reduction with atorvastatin and simvastatin only, and not with pravastatin and rosuvastatin.
CONCLUSIONS: Atorvastatin and simvastatin, but not the other statins, can reduce serum uric acid levels.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27260336     DOI: 10.1007/s40265-016-0591-2

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  37 in total

1.  Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.

Authors:  M Tomita; S Mizuno; H Yamanaka; Y Hosoda; K Sakuma; Y Matuoka; M Odaka; M Yamaguchi; H Yosida; H Morisawa; T Murayama
Journal:  J Epidemiol       Date:  2000-11       Impact factor: 3.211

Review 2.  Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Amirhossein Sahebkar; Jana Rathouska; Luis E Simental-Mendía; Petr Nachtigal
Journal:  Pharmacol Res       Date:  2015-11-04       Impact factor: 7.658

Review 3.  Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.

Authors:  Amirhossein Sahebkar; Corina Serban; Dimitri P Mikhailidis; Anetta Undas; Gregory Y H Lip; Paul Muntner; Vera Bittner; Kausik K Ray; Gerald F Watts; G Kees Hovingh; Jacek Rysz; John J P Kastelein; Maciej Banach
Journal:  Thromb Haemost       Date:  2015-05-28       Impact factor: 5.249

4.  Targeting vascular risk in patients with metabolic syndrome but without diabetes.

Authors:  Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Triandafillos P Didangelos; Athanasia Peletidou; Drosia Kleta; Asterios Karagiannis; Anna I Kakafika; Konstantinos Tziomalos; Moses Elisaf
Journal:  Metabolism       Date:  2005-08       Impact factor: 8.694

5.  Impaired lipoprotein metabolism in patients with primary gout--influence of alcohol intake and body weight.

Authors:  S Takahashi; T Yamamoto; Y Moriwaki; Z Tsutsumi; K Higashino
Journal:  Br J Rheumatol       Date:  1994-08

6.  Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials.

Authors:  James McKenney; Harold Bays; Gilbert Gleim; Yale Mitchel; Olga Kuznetsova; Aditi Sapre; Waheeda Sirah; Darbie Maccubbin
Journal:  J Clin Lipidol       Date:  2015-03-02       Impact factor: 4.766

Review 7.  Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Giuseppe Derosa; Pamela Maffioli; Amirhossein Sahebkar
Journal:  Pharmacol Res       Date:  2015-09-15       Impact factor: 7.658

8.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

9.  Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.

Authors:  Haralampos J Milionis; Anna I Kakafika; Sofia G Tsouli; Vasilios G Athyros; Eleni T Bairaktari; Konstantinos I Seferiadis; Moses S Elisaf
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

10.  Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Authors:  Vasilios G Athyros; Moses Elisaf; Athanasios A Papageorgiou; Athanasios N Symeonidis; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Haralambos J Milionis; Dimitri P Mikhailidis
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  16 in total

Review 1.  Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.

Authors:  Amirhossein Sahebkar; Renato Giua; Claudio Pedone
Journal:  Br J Clin Pharmacol       Date:  2016-10-04       Impact factor: 4.335

Review 2.  Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications.

Authors:  Nicole Leung; Kevin Yip; Michael H Pillinger; Michael Toprover
Journal:  Mayo Clin Proc       Date:  2022-07       Impact factor: 11.104

3.  Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Authors:  Xin-Yao Liu; Qiao-Yu Wu; Zhi-Heng Chen; Guang-Yu Yan; Yao Lu; Hai-Jiang Dai; Ying Li; Ping-Ting Yang; Hong Yuan
Journal:  Endocrine       Date:  2020-01-15       Impact factor: 3.633

4.  Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.

Authors:  Xiaole Su; Boyang Xu; Bingjuan Yan; Xi Qiao; Lihua Wang
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

5.  Sex-Specific Association Between Serum Uric Acid and Retinal Microvessels.

Authors:  Qiaowei Li; Fan Lin; Zhonghai Gao; Feng Huang; Pengli Zhu
Journal:  Med Sci Monit       Date:  2019-12-25

6.  Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017.

Authors:  Minkook Son; Jeongkuk Seo; Sung Yang
Journal:  PLoS One       Date:  2020-02-14       Impact factor: 3.240

7.  Association between Lipid Profiles and Serum Urate: A Cross-Sectional Study in Southwestern China.

Authors:  Jiying Qi; Xiaojuan Dai; Binbin Zhou; Yang Su; Zhen Xie; Dongmei Liu
Journal:  Int J Endocrinol       Date:  2021-07-08       Impact factor: 3.257

8.  Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

9.  Inverse associations between serum urate and glycemic status in a general population and in persons with diabetes mellitus.

Authors:  Ichiro Wakabayashi
Journal:  Diabetol Metab Syndr       Date:  2020-03-10       Impact factor: 3.320

Review 10.  Hyperuricemia, the heart, and the kidneys - to treat or not to treat?

Authors:  Tadej Petreski; Robert Ekart; Radovan Hojs; Sebastjan Bevc
Journal:  Ren Fail       Date:  2020-11       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.